
Startups & growth Analysis
CpG Diagnostics develops a blood test for a difficult ovarian-mass decision
CpG Diagnostics is developing OvaPrint to help clinicians assess an ovarian-area mass before treatment, with clinical validation underway.

Bodour Salhia is the founder and CEO of CpG Diagnostics. OvaPrint originated in research from her laboratory.
Loading profile details…
Loading recent changes…
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Profile reviewed . Values carry their own dates.